Clinical Trials Directory

Trials / Completed

CompletedNCT02437448

Breath Analysis in Lung Fibrosis

Exhaled Breath Analysis by Secondary Electrospray Ionization - Mass Spectrometry (SESI-MS) in Patients With Pulmonary Fibrosis

Status
Completed
Phase
Study type
Observational
Enrollment
31 (actual)
Sponsor
University of Zurich · Academic / Other
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to answer the question whether a disease specific profile of breath in patients with idiopathic lung fibrosis can be detected by an untargeted metabolomic study using exhaled breath analysis by mass spectrometry.

Conditions

Interventions

TypeNameDescription
OTHERNo intervention

Timeline

Start date
2015-06-01
Primary completion
2018-12-01
Completion
2018-12-01
First posted
2015-05-07
Last updated
2020-10-05

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT02437448. Inclusion in this directory is not an endorsement.

Breath Analysis in Lung Fibrosis (NCT02437448) · Clinical Trials Directory